EMR
−$811.2K
5,700 sh @ $142
Karsanbhai Surendralal Lanca
Director, President & CEO, CEO and President, CEO & President, Chief Executive Officer, Exec Pres Auto Sols · SEC CIK 1754881Advertisement
Buy track record
How this insider's open-market purchases have performed100%
of buys now in profit
1 up · 0 down
Avg return since buy+77.7%
Median return+77.7%
Best trade+77.7%
Worst trade+77.7%
Buys scored1
Average return by holding period — separates good entry timing from riding one long winner
After 1 month
+7.6%
100% won · 1 trade
After 3 months
+18.0%
100% won · 1 trade
After 6 months
+27.7%
100% won · 1 trade
After 12 months
+47.4%
100% won · 1 trade
| Date | Company | 90d trend | Buy price | Value | ΔOwn | 1M | 3M | 6M | 12M | To date |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 17, 2023 | EMR | $88 | $882K | +7.2% | +7.6% | +18.0% | +27.7% | +47.4% | +77.7% |
How this is calculated. We score only open-market purchases (SEC code
P) — the buys that carry real signal. Each trade's return is measured from the adjusted closing price on the purchase date to the latest close, accounting for stock splits and dividends. The 1M/3M/6M/12M columns show the same trade's return after each fixed holding period; a dash means that horizon hasn't elapsed yet or isn't priceable. Sales are excluded because insiders sell for many routine reasons. With only 1 scored trade, treat this as a small sample, not a verdict.
Advertisement
Open-market buys
$882K
1 trades
Open-market sells
$12.17M
8 trades
Net flow
−$11.29M
Net selling
Total filings
50
transactions shown
Full transaction history
All Form 4 activity across every company, newest firstEMR
+$0
5,578 sh
EMR
−$655K
4,422 sh @ $148
EMR
+$0
3,120 sh
EMR
−$0
2,267 sh
Advertisement
EMR
+$465.3K
10,227 sh @ $46
EMR
−$394.2K
2,964 sh @ $133
EMR
−$966K
7,263 sh @ $133
EMR
+$217.2K
4,773 sh @ $46
EMR
−$217.2K
1,653 sh @ $131
EMR
+$0
115,705 sh
EMR
−$1.33M
10,016 sh @ $133
EMR
−$1.25M
9,022 sh @ $138
EMR
+$0
54,475 sh
EMR
−$10.05M
72,061 sh @ $139
EMR
−$1.89M
16,698 sh @ $113
EMR
+$0
12,698 sh
EMR
−$6.84M
52,409 sh @ $131
EMR
+$0
72,282 sh
EMR
−$1.26M
10,038 sh @ $125
EMR
+$0
61,441 sh
EMR
−$6.23M
57,140 sh @ $109
EMR
+$0
542 sh
EMR
+$251.4K
4,000 sh @ $63
EMR
−$34.1K
322 sh @ $106
EMR
−$83.9K
792 sh @ $106
EMR
−$248.5K
2,344 sh @ $106
EMR
Karsanbhai Surendralal Lanca, EMR's CEO, spent $882K of their own money on 10,000 shares at $88, growing their stake 7%.
+$882K
10,000 sh @ $88
EMR
+$0
67,655 sh
EMR
+$0
63,208 sh
Frequently asked questions
How is Karsanbhai Surendralal Lanca's win rate calculated?
We take every open-market purchase (SEC code P) we can match to a stock price, then compare the split- and dividend-adjusted price on the purchase date to the most recent close. The win rate is the share of those buys currently trading above the purchase price. Sales and share grants are not scored.
Why are some buys not included in the score?
A purchase is excluded if we can't price it — for example if the ticker is missing from the filing, the company has been delisted, or the security isn't a common stock we can match to market data. Excluded counts are shown next to the scored total.
What do the 1M / 3M / 6M / 12M columns mean?
They show each purchase's return after a fixed holding period — one, three, six, and twelve months from the buy date — using split- and dividend-adjusted prices. This separates good entry timing from simply holding a long-running winner. A dash means that horizon hasn't elapsed yet for that trade, or the stock couldn't be priced at that date.
Does a high win rate mean I should copy this insider?
No. Past performance does not predict future results, sample sizes are often small, and an insider's edge in their own company doesn't transfer to yours. This is context, not a recommendation. InsiderSource is not investment advice.
Where does this data come from?
Trades come from Karsanbhai Surendralal Lanca's SEC Form 4 filings on EDGAR. Prices come from public market data and are split/dividend-adjusted. Always verify against the original filings before acting.